SCHEMBL3457560

SCHEMBL3457560

Cc1cc2nc(-c3[nH]nc4c3CCN(CCc3ccccc3)C4)[nH]c2cc1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 3/20 0.41
HTR1A P08908 1/20 0.41
HTR2A P28223 1/20 0.41
DRD4 P21917 2/20 0.41
DRD3 P35462 2/20 0.41
BRS3 P32247 1/20 0.39
CYP1A2 P05177 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
METAP2 P50579 1/20 0.38
METAP1 P53582 1/20 0.38
CBFB Q13951 1/20 0.38
GRM2 Q14416 1/20 0.38
INSR P06213 2/20 0.37
IGF1R P08069 2/20 0.37
MET P08581 2/20 0.37
ALK Q9UM73 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3456014 0.94 GRIN2B (0.41) DRD2HTR1ADRD3GRM2KMT2A
SCHEMBL3455866 0.90 DRD2 (0.44) DRD2DRD4DRD3BRS3CYP1A2
SCHEMBL3455936 0.86 ALDH1A1 (0.38) CYP1A2CYP2C9CYP2C19SMN1; SMN2METAP2
SCHEMBL3460034 0.84 ALDH1A1 (0.37) HTR1ASMN1; SMN2METAP2METAP1CBFB
SCHEMBL3455100 0.84 BRD4 (0.38) CYP1A2CYP2C9CYP2C19SMN1; SMN2METAP2
SCHEMBL3461019 0.83 GRIA1 (0.39) CYP1A2CYP2C9CYP2C19SMN1; SMN2CYP3A4
SCHEMBL14032049 0.83 GPBAR1 (0.42) CYP1A2CYP2C9CYP2C19SMN1; SMN2CYP3A4
SCHEMBL5067955 0.82 SMN1; SMN2 (0.45) CYP1A2CYP2C9CYP2C19SMN1; SMN2CYP3A4
SCHEMBL3456801 0.82 KIT (0.41) DRD2CYP3A4GRM2CLPP
SCHEMBL3455104 0.82 MEN1 (0.47) DRD2DRD4DRD3MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2251340-A1 Substituted tetrahydro-1h-pyrazolo[3,4-c] pyridines, compositions containing same and use thereof Aventis Pharma S.A. (FR) 2010-11-17 EP disclosed
US-7435820-B2 Substituted tetrahydro-1H-pyrazolo [3,4-c]pyridines compositions comprising them, and use AVENTIS PHARMA S.A. (FR) 2008-10-14 US disclosed
US-7435820-B2 Substituted tetrahydro-1H-pyrazolo [3,4-c]pyridines compositions comprising them, and use AVENTIS PHARMA S.A. (FR) 2008-10-14 US disclosed